Thyroid Function and the Cardiac Disposition of Catecholamines
- 1 July 1963
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 73 (1), 63-74
- https://doi.org/10.1210/endo-73-1-63
Abstract
Hyperthyroid rats show an elevated and prolonged hemodynamic response to injected epinephrine; hypothyroid rats have lower base-line blood pressures than control animals, but show a normal response to the catecholamine. Hyperthyroid rats shunt a larger fraction of the cardiac output to their enlarged hearts, thus delivering a greater proportion of a dose of H3-epinephrine to this organ. Each gram of hyperthyroid heart receives the same fraction of circulating H3-epinephrine as an equal weight of normal heart, but its capacity to inactivate the H3-epinephrine by binding is diminished. The consequent maintenance of elevated levels of free epinephrine may be a major factor in the development of the altered hemodynamic response of the hyperthyroid animal to epinephrine. A single large dose of thyroxine has no effect on the uptake, binding or release of H3- epinephrine by the heart, or the hypertensive response induced by a given dose of the neurohumor. Hypothyroid hearts receive and bind as much circulating epinephrine as normal hearts, in spite of their decreased weight. One hour after H3-epinephrine administration they contain greater amounts of the H3-metabolites, while hyperthyroid hearts contain smaller quantities. This difference is probably related to washout by the circulating blood. Although hyperthyroidism increases hepatic monoamine oxidase activity in the female, and hypothyroidism decreases it in the male, hyperthyroidism is associated with a decrease and hypothyroidism with an increase in deaminated metabolites of H3-epinephrine in the heart. Neither cardiac nor hepatic catechol-Omethyl transferase activity is altered by doses of thyroxine which produce hyperresponsiveness to epinephrine. It is concluded that at least a part of the mechanism of the increased cardiovascular sensitivity to epinephrine found in hyperthyroidism is not due to changes in the activities of the enzymes which metabolize epinephrine, but is related to a decreased ability of each unit weight of heart to inactivate this catecholamine by binding. More “free” epinephrine is available in the heart to act on its physiologic receptors.Keywords
This publication has 14 references indexed in Scilit:
- The Metabolic Fate of H3-Epinephrine and C14-Metanephrine in the RatJournal of Biological Chemistry, 1961
- Thyroxine Stimulation of Amino Acid Incorporation into ProteinJournal of Biological Chemistry, 1961
- EFFECT OF DRUGS ON UPTAKE AND METABOLISM OF H3-NOREPINEPHRINE1961
- AUGMENTATION OF PHARMACOLOGICAL PROPERTIES OF CATECHOLAMINES BY O-METHYL TRANSFERASE INHIBITORS1960
- Metabolism of Epinephrine and Other Sympathomimetic AminesPhysiological Reviews, 1959
- Inhibitor of O-Methylation of Epinephrine and Norepinephrine in vitro and in vivoScience, 1959
- Inhibition of O-Methyltransferase by Catechol and Sensitization to EpinephrineScience, 1959
- Enzymatic O-Methylation of Epinephrine and Other CatecholsJournal of Biological Chemistry, 1958
- Regional Blood Flow by Fractional Distribution of IndicatorsAmerican Journal of Physiology-Legacy Content, 1958
- Potentiating Effect of Iproniazid on the Pharmacological Action of Sympathomimetic Amines.Experimental Biology and Medicine, 1953